CAR NK cell therapy is a novel immunotherapy made from natural killer (NK) cells engineered to better recognize and eliminate cancer cells At UT MD...
PARP inhibitors are among the most widely used therapies for ovarian cancer, but their long-term effectiveness is limited by acquired resistance Researchers...
About the Study: Cardiology practitioners need to remain updated on rapidly evolving breast cancer therapies to care for this growing,...
WASHINGTON -- While there has been a recent increase among Medicare recipients in genomic testing that helps match cancer patients...
Zhang, R., Wei, Z. Comment on: ‘Modelled impact of a multi-cancer early detection screening programme on cancer treatment in England’....
Newly published work in Neuro-Oncology spotlights a molecular vulnerability in glioblastoma (GBM), the most aggressive primary brain tumor. The study,...
Multiple myeloma (MM) treatment is entering a “de-escalation” era: clinicians aim to preserve deep, durable disease control while lowering long-term...
Insilico Medicine has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ISM6331, an...
Hospitals are not only places where childhood cancer is treated—they also generate records of earlier health encounters. A new population-based...
A new analysis published in British Journal of Cancer maps how oncology drug development in the UK has evolved over...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine